Patient attitudes and understanding about biosimilars: an international cross-sectional survey
نویسندگان
چکیده
OBJECTIVE To understand the levels of awareness, usage, and knowledge of biosimilars among patients, caregivers, and the general population in the US and the European Union; perceptions of biosimilars compared to originator biologics; perceived benefits and drawbacks of clinical trials; and whether advocacy groups impact patients' willingness to try a biosimilar. METHODS An international survey was conducted which contained up to 56 closed-ended (requiring yes/no or ranking answers) and open-ended questions, depending on the population assigned. The survey was divided into distinct sections, including medication-class awareness, usage, and knowledge about biologic and biosimilar therapies; perceptions of clinical trials; and involvement in advocacy groups. Interviews were conducted in adults categorized as: 1) diagnosed: patients with inflammatory bowel disease including Crohn's disease and ulcerative colitis, rheumatoid arthritis, psoriasis, breast cancer, lung cancer, colorectal cancer, or non-Hodgkin's lymphoma; 2) diagnosed advocacy: individuals with these diseases who participated in patient support groups; 3) caregiver: has a loved one with these conditions and is involved in medical decisions; 4) general population: aged 18-64 years, without these conditions. Statistical analyses among groups within a region (US or EU) used column proportions test with a 95% confidence interval. RESULTS In all, 3,198 individuals responded. Awareness about biologic therapies was significantly higher in diagnosed, diagnosed advocacy, and caregiver groups (45%-78%) versus general population (27%; P<0.05). Across all groups, awareness of biosimilars was low; only 6% of the general population reported at least a general impression of biosimilars. Awareness was significantly higher in the diagnosed advocacy group (20%-30%; P<0.05). Gaps in knowledge about biosimilars included safety, efficacy, and access to these agents. Respondents had generally positive perceptions of clinical trials, although barriers to participation were identified. CONCLUSION An immediate need exists for patient education about biosimilars and clinical trials to ensure educated and informed decisions are made about biosimilar use.
منابع مشابه
Patient Understanding and Attitudes About Biosimilars: An International Cross-Sectional Survey.
REFERENCES 1. Scientific considerations in demonstrating biosimilarity to a reference product: guidance for industry. US FDA; 2015. 2. Guidelines on evaluation of similar biotherapeutic products (SBPs). WHO; 2009. 3. Guideline on similar biological medicinal products. EMA; 2014. 4. Column proportions test [user guide]. IBM Corporation; 2013. 5. Leading autoimmune patient advocacy group survey f...
متن کاملAssessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany
OBJECTIVES We examined rheumatologists' motivation for prescribing biosimilars, assessed their treatment preferences in relation to prescribing behavior and explored patient attitudes to biosimilars. METHODS Data were taken from the Adelphi Real World Biosimilars Programme, a real-world, cross-sectional study undertaken with German rheumatologists and patients with rheumatoid arthritis, ankyl...
متن کاملAssessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany
OBJECTIVES This study examined gastroenterologists' motivation for prescribing biosimilars, assessed their treatment preferences in relation to prescribing behaviour, and explored patient attitudes to biosimilars. METHODS Data were taken from the Adelphi Real World Biosimilars Programme, a real-world, cross-sectional study undertaken in 2015-2016 with German gastroenterologists and patients w...
متن کاملSurvey of attitudes about patient safety in pre-hospital emergency operating staff of Mashhad-Iran in 2019
Background and Aims: patient safety is a very important and necessary component and one of the main elements of quality in health and medical organizations, despite this, the patient safety situation in the pre-hospital emergency system is very ambiguous and there is almost no information about adverse complications. Assessing the current safety culture can be a starting point for improving saf...
متن کاملPatient safety and medical errors: knowledge, attitudes and behavior among Italian hospital physicians.
OBJECTIVE To investigate physicians' knowledge about evidence-based patient safety practices, their attitudes on preventing and managing medical errors and to explore physicians' behavior when facing medical errors. DESIGN A nationwide cross-sectional survey. SETTING We first stratified our population by the 20 Italian regions. Then, within each stratum, we selected by simple random samplin...
متن کامل